Of these, mutations involving the PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor are amongst the most commonly encountered, with loss of function mutations being reported in ∼30% of primary cancers, and in more than 60% of metastases (reviewed in [3]). Here, PTEN is linked to cancer.